- BUZZ-Inovio shares plunge after $75 million stock sale to fund development of rare throat disease drug
- CORPAY, INC. <CPAY.N>: MIZUHO RAISES TARGET PRICE TO $460 FROM $390
- AMPLITUDE, INC. : CITIGROUP RAISES TARGET PRICE TO $18 FROM $11
- MKS INCORPORATED <MKSI.O>: MIZUHO CUTS TARGET PRICE TO $290 FROM $330
- TELUS Declares Quarterly Dividend of CAD 0.1875 Per Share
- TELUS Appoints Marc Allera and Bill Thomas to Board, Effective Jan. 1, 2027
- LYFT, INC. <LYFT.O>: MIZUHO RAISES TARGET PRICE TO $18 FROM $15
- BRIEF-Senstar Technologies Q3 Revenue USD 13.1 Million
- IONQ, INC. <IONQ.N>: MIZUHO CUTS TARGET PRICE TO $42 FROM $52
- HAEMONETICS CORP <HAE.N>: MIZUHO RAISES TARGET PRICE TO $165 FROM $140
- GRAIL INC <GRAL.O>: MIZUHO RAISES TARGET PRICE TO $110 FROM $100
- MICROCHIP TECHNOLOGY <MCHP.O>: MIZUHO CUTS TARGET PRICE TO $90 FROM $112
- MNTN, INC. <MNTN.N>: CITIGROUP CUTS TO NEUTRAL FROM BUY; CUTS TARGET PRICE TO $7 FROM $16
- PARKER-HANNIFIN CORPORATION : MIZUHO CUTS TARGET PRICE TO $1,075 FROM $1,200
- PAYCOM SOFTWARE, INC. : MIZUHO RAISES TARGET PRICE TO $260 FROM $160
- MARTIN MARIETTA MATERIALS, INC. <MLM.N>: CITIGROUP RAISES TARGET PRICE TO $641 FROM $610
- Spot platinum surpasses $1,530 per ounce, up 0.89% on the day
- PULSE BIOSCIENCES, INC. : MIZUHO RAISES TARGET PRICE TO $65 FROM $55
- EMERSON <EMR.N>: MIZUHO RAISES TARGET PRICE TO $190 FROM $180
- BRIEF-Moderna Q3 EPS USD 0.38 Vs. IBES Estimate USD -1.25
- BRIEF-Telus Corp Q3 Net Income CAD -660 Million
- BRIEF-Airsculpt Technologies Q3 Adjusted EBITDA USD 400 Thousand
- AirSculpt Q3 FY26 net loss narrows 25% to $7.17 million
- CONOCOPHILLIPS <COP.N>: MIZUHO RAISES TARGET PRICE TO $149 FROM $146
- XRP falls below $1.20, analysts warn of deeper drop if $1.16 support breaks
- Major Canadian Economic Indicators Expected This Week
- Moderna: Following Phase 3 Interim Analysis of mRNA-1403, Which Did Not Meet Statistical Criteria for Early Success, Co. Does Not Plan to Initiate Additional Cohort This Season >MRNA
- Moderna Sees 2026 Capital Spending of About $200M Vs Prior View $200M-$300M >MRNA
- Moderna: Continue to Expect About Half of 2026 Revenue to Come From U.S. and Half From International Markets >MRNA
- Moderna 3Q R&D Expenses Fell 27%, Primarily Driven by Lower Clinical Development Costs Following Completion and Wind-Down of Certain Late-Stage Studies in Infectious Disease Portfolio, and Continued Cost Efficiencies Across Organization >MRNA
- Moderna 3Q U.S. Revenue $780M >MRNA
- Moderna: Cash, Cash Equivalents and Investments $8B as of Sept. 30 >MRNA
- CARDINAL HEALTH, INC. <CAH.N>: MIZUHO RAISES TARGET PRICE TO $290 FROM $280
- BENTLEY SYSTEMS, INCORPORATED <BSY.O>: MIZUHO RAISES TARGET PRICE TO $55 FROM $45
- QUANTINUUM INC <QNT.O>: MIZUHO CUTS TARGET PRICE TO $70 FROM $90
- AIG : MIZUHO RAISES TARGET PRICE TO $89 FROM $83
- Atmus Filtration Techs Raises 2026 View To Adj EPS $2.90-Adj EPS $3.05 >ATMU
- AIR PRODUCTS : MIZUHO RAISES TARGET PRICE TO $360 FROM $355
- Atmus Q3 2026 net income rises 11% year over year to $60.6 million
- SIMON PROPERTY GROUP INC <SPG.N>: MIZUHO RAISES TARGET PRICE TO $239 FROM $226
- ACADIA HEALTHCARE COMPANY, INC. : MIZUHO RAISES TARGET PRICE TO $36 FROM $31
- BD <BDX.N>: CITIGROUP RAISES TARGET PRICE TO $241 FROM $208
- Atmus Filtration Techs 3Q Sales $510M >ATMU
- Atmus Filtration Techs 3Q Adj EPS 77c >ATMU
- Atmus Filtration Techs 3Q EPS 74c >ATMU
- Atmus Filtration Techs Raises 2026 View To Sales $2.01B-$2.035B >ATMU
- TARSUS PHARMACEUTICALS, INC. <TARS.O>: MIZUHO RAISES TARGET PRICE TO $102 FROM $94
- TARGA RESOURCES CORP. <TRGP.N>: CITIGROUP RAISES TARGET PRICE TO $338 FROM $325
- Telefônica Brasil Names Ernesto Daniel Gardelliano to Board, Replacing Ignácio Maria Moreno Martínez
- ALLSTATE CORP : MIZUHO RAISES TARGET PRICE TO $311 FROM $295
- Agomab Therapeutics Director David R. Epstein Reports $103,500 Common Share Acquisition
- Purple Group Expects FY2026 Headline EPS to Rise 22.3%-32.3%
- AIRBNB, INC. : WELLS FARGO RAISES TARGET PRICE TO $215 FROM $185
- EPAM SYSTEMS, INC. <EPAM.N>: WELLS FARGO RAISES TARGET PRICE TO $176 FROM $156
- UNITY SOFTWARE, INC. <U.N>: WELLS FARGO RAISES TARGET PRICE TO $64 FROM $53
- COMPASS, INC. <COMP.N>: WELLS FARGO CUTS TARGET PRICE TO $9 FROM $10
- APPLOVIN CORP. : WELLS FARGO RAISES TARGET PRICE TO $347 FROM $325
- IMAX CORPORATION <IMAX.N>: WELLS FARGO CUTS TARGET PRICE TO $52 FROM $55
- LAMAR ADVERTISING COMPANY <LAMR.O>: WELLS FARGO RAISES TARGET PRICE TO $158 FROM $156
- NEXSTAR MEDIA GROUP, INC. <NXST.O>: WELLS FARGO RAISES TARGET PRICE TO $250 FROM $249
- LIVE NATION ENTERTAINMENT, INC. <LYV.N>: WELLS FARGO CUTS TARGET PRICE TO $221 FROM $222
- CENTURY ALUMINUM COMPANY <CENX.O>: WELLS FARGO CUTS TARGET PRICE TO $71 FROM $79
- CENTURI HOLDINGS, INC. <CTRI.N>: WELLS FARGO CUTS TARGET PRICE TO $24 FROM $28
- SOLARIS ENERGY INFRASTRUCTURE, INC. <SEI.N>: WELLS FARGO CUTS TARGET PRICE TO $65 FROM $72
- FATE THERAPEUTICS, INC. <FATE.O>: WELLS FARGO CUTS TARGET PRICE TO $3 FROM $3.5
- SOLVENTUM CORPORATION <SOLV.N>: WELLS FARGO RAISES TARGET PRICE TO $95 FROM $89
- AMPHASTAR PHARMACEUTICALS, INC. : WELLS FARGO RAISES TARGET PRICE TO $25 FROM $20
- VERISK ANALYTICS, INC. <VRSK.O>: WELLS FARGO RAISES TARGET PRICE TO $265 FROM $260
- CUMMINS INC. <CMI.N>: WELLS FARGO CUTS TARGET PRICE TO $520 FROM $608
- PRIMORIS SERVICES CORPORATION : WELLS FARGO CUTS TARGET PRICE TO $64 FROM $85
- HALOZYME THERAPEUTICS, INC. <HALO.O>: WELLS FARGO RAISES TARGET PRICE TO $110 FROM $95
- OMADA HEALTH, INC. <OMDA.O>: WELLS FARGO CUTS TARGET PRICE TO $19 FROM $22
- TANDEM DIABETES CARE, INC. <TNDM.O>: WELLS FARGO CUTS TARGET PRICE TO $25 FROM $27
- TELEFLEX INCORPORATED <TFX.N>: WELLS FARGO RAISES TARGET PRICE TO $167 FROM $138
- ENOVIS CORPORATION <ENOV.N>: WELLS FARGO RAISES TARGET PRICE TO $37 FROM $33
- GLOBUS MEDICAL, INC. <GMED.N>: WELLS FARGO RAISES TARGET PRICE TO $100 FROM $99
- JBG SMITH Properties Declares Dividend of $0.175 >JBGS
- CORRECTED-BRIEF-Bloomin' Brands Q3 Adjusted EPS USD -0.17 Vs. IBES Estimate USD -0.24
- CORRECTED-BRIEF-PSQ Holdings Q3 Revenue USD 7.3 Million
- Brookdale Senior Living 3Q Loss/Shr 6c >BKD
- Brookdale Senior Living 3Q Rev $712.1M >BKD
- U.S. Political, Economic Calendar - Week Ahead
- Delek US 3Q EPS $18.22 >DK
- Brookdale Senior Living Q3 Loss Narrows, Revenue Falls
- -- Earnings Flash (T.TO) TELUS Corporation Reports Q3 Revenue CA$5.02B, vs. FactSet Est of CA$4.98B
- -- Earnings Flash (T.TO) TELUS Corporation Posts Q3 Adjusted EPS CA$0.16 vs. FactSet Est of CA$0.17
- --Earnings Flash (MRNA) Moderna Posts Q3 EPS $0.38, vs. FactSet Est of $1.10 Loss
- -- Earnings Flash (MRNA) Moderna, Inc. Reports Q3 Revenue $1.31B, vs. FactSet Est of $890.3M
- Essent Group Q3 Earnings, Revenue Rise
- --GUIDANCE: (ATMU) Atmus Filtration Technologies Expects 2026 Net Sales Range of $2.01B - $2.04B, vs. FactSet Est of $2.01B
- Delek US Q3 Adjusted Earnings, Revenue Rise
- -- Earnings Flash (ATMU) Atmus Filtration Technologies Inc. Posts Q3 Adjusted EPS $0.77 per Share, vs. FactSet Est of $0.77
- --Earnings Flash (MMI) Marcus & Millichap Posts Q3 EPS $0.03, vs. FactSet Est of $0.07
- --GUIDANCE: (ATMU) Atmus Filtration Technologies Expects 2026 Adjusted EPS Range $2.90 to $3.05
- -- Earnings Flash (ATMU) Atmus Filtration Technologies Inc. Reports Q3 Revenue $510.0M, vs. FactSet Est of $501.6M
- --Earnings Flash (MMI) Marcus & Millichap Posts Q3 Total Revenue $208.4M, vs. FactSet Est of $205.1M
- PepsiCo Renews KFC Beverage Partnership Across Eight International Markets
- Central Bank Action, Geopolitics, Pressure European Bourses Midday
- --Earnings Flash (AQN) Algonquin Power & Utilities Posts Q3 Revenue $642.5M
- Veon's Beeline Kazakhstan Closes OLX KZ Acquisition for $81 Million
